Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.

Pan HX, Qiu LX, Liang Q, Chen Z, Zhang ML, Liu S, Zhong GH, Zhu KX, Liao MJ, Hu JL, Li JX, Xu JB, Fan Y, Huang Y, Su YY, Huang SJ, Wang W, Han JL, Jia JZ, Zhu H, Cheng T, Ye XZ, Li CG, Wu T, Zhu FC, Zhang J, Xia NS.

Open source

DOI: 10.1016/s1473-3099(24)00159-2
Published: 2024-04-10
Container: Lancet Infect Dis
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-24-00159-2,
  title = {Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.},
  author = {Pan HX and  Qiu LX and  Liang Q and  Chen Z and  Zhang ML and  Liu S and  Zhong GH and  Zhu KX and  Liao MJ and  Hu JL and  Li JX and  Xu JB and  Fan Y and  Huang Y and  Su YY and  Huang SJ and  Wang W and  Han JL and  Jia JZ and  Zhu H and  Cheng T and  Ye XZ and  Li CG and  Wu T and  Zhu FC and  Zhang J and  Xia NS.},
  year = {2024},
  journal = {Lancet Infect Dis},
  doi = {10.1016/s1473-3099(24)00159-2},
  url = {https://doi.org/10.1016/s1473-3099(24)00159-2}
}

RIS

TY  - JOUR
TI  - Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
AU  - Pan HX
AU  -  Qiu LX
AU  -  Liang Q
AU  -  Chen Z
AU  -  Zhang ML
AU  -  Liu S
AU  -  Zhong GH
AU  -  Zhu KX
AU  -  Liao MJ
AU  -  Hu JL
AU  -  Li JX
AU  -  Xu JB
AU  -  Fan Y
AU  -  Huang Y
AU  -  Su YY
AU  -  Huang SJ
AU  -  Wang W
AU  -  Han JL
AU  -  Jia JZ
AU  -  Zhu H
AU  -  Cheng T
AU  -  Ye XZ
AU  -  Li CG
AU  -  Wu T
AU  -  Zhu FC
AU  -  Zhang J
AU  -  Xia NS.
PY  - 2024
JO  - Lancet Infect Dis
DO  - 10.1016/s1473-3099(24)00159-2
UR  - https://doi.org/10.1016/s1473-3099(24)00159-2
ER  -

APA

HX, P., LX, Q., Q, L., Z, C., ML, Z., S, L., GH, Z., KX, Z., MJ, L., JL, H., JX, L., JB, X., Y, F., Y, H., YY, S., SJ, H., W, W., JL, H., JZ, J., H, Z., T, C., XZ, Y., CG, L., T, W., FC, Z., J, Z., & NS., X. (2024). Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.. Lancet Infect Dis. https://doi.org/10.1016/s1473-3099(24)00159-2

Source records

europe-pmc · retrieved 2026-09-26T20:48:12.565Z